Followers | 806 |
Posts | 30081 |
Boards Moderated | 5 |
Alias Born | 03/22/2016 |
Monday, November 01, 2021 3:05:17 PM
Recent ATHA News
- Athira Pharma to Participate in Upcoming May Conferences • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease • GlobeNewswire Inc. • 04/11/2024 11:00:00 AM
- Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/22/2024 09:34:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:10:13 PM
- Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:01:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:54:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:46:40 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:40:35 PM
- Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS) • GlobeNewswire Inc. • 02/08/2024 09:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:38:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:36:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 09:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:11:45 PM
- Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update • GlobeNewswire Inc. • 01/08/2024 12:00:00 PM
- Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Athira Pharma Announces Encouraging Results from SHAPE Phase 2 Clinical Trial of Fosgonimeton for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies • GlobeNewswire Inc. • 12/12/2023 12:00:00 PM
- Athira Pharma to Participate in Sidoti December Small Cap Investor Conference • GlobeNewswire Inc. • 11/29/2023 12:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM